Cornell Scientists Have Identified a New Incredibly Common Subtype of Prostate Cancer
A new and very prevalent kind of prostate cancer A recent study by a group of researchers at Memorial Sloan Kettering Cancer Center (MSK) and…
A new and very prevalent kind of prostate cancer A recent study by a group of researchers at Memorial Sloan Kettering Cancer Center (MSK) and…
A Cedars-Sinai cancer study indicates improved survival following a combination of hormone therapy and pelvic lymph node treatment A combination of androgen deprivation therapy—a common…
Men with advanced prostate cancer who took abiraterone or enzalutamide in conjunction with hormone treatment had a greater risk of major medical complications than those…
Therapy sensitivity in prostate cancer halted by protein regulating circadian rhythm. Hormone treatment is successful at controlling metastatic prostate cancer, but the tumor cells eventually…
Smoking worsens the prognosis for men with prostate cancer According to a large population study led by Lund University in Sweden, smokers had a decreased…
First-of-its-kind meta-analysis published in The Lancet Oncology. Prostate cancer is the leading cause of cancer in men worldwide, and radiotherapy is one of the common…
A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers. While researchers…
RNA molecule suppresses prostate tumor growth. Many patients with prostate cancer are treated with drugs that lower or block hormones that fuel tumor growth. While…
Cleveland Clinic study links gut microbiome and aggressive prostate cancer. Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut…
Greatest risk seems to be among earliest responders on day of attack. The risk of prostate cancer was 24% higher among 9/11 rescue and recovery…
A new class of drug successfully targets treatment-resistant prostate cancers and prolongs the life of patients. The treatment delivers beta radiation directly to tumor cells,…
Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to…
Mouse study suggests mushrooms may suppress androgen receptor activity. The chemicals present in white button mushrooms may slow the progression of prostate cancer, according to…
An INRS team is investigating the relationship between body mass and the risk of developing cancer. Prostate cancer is the most common form of cancer…
In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas…
A technique that delivers high-intensity focused ultrasound to targeted tissue under MRI guidance effectively treats intermediate-risk prostate cancer with minimal side effects, according to a…
Secondary analysis of the VITAL Randomized Clinical Trial found an overall 17 percent risk reduction for metastatic or fatal cancer and a 38 percent reduction…
A study published today (July 27, 2020) in The Lancet Digital Health by UPMC and University of Pittsburgh researchers demonstrates the highest accuracy to date in…